Wikidata

(Q34559914)

English

Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period

scientific article

In more languages

Statements

title
Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
16083542
retrieved
3 August 2017
author name string
Roger Bullock
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
16083542
retrieved
3 August 2017
Jacques Touchon
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
16083542
retrieved
3 August 2017
Giuseppe Gambina
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
16083542
retrieved
3 August 2017
Yunsheng He
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
16083542
retrieved
3 August 2017
Günter Rapatz
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
16083542
retrieved
3 August 2017
Jennifer Nagel
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
16083542
retrieved
3 August 2017
page(s)
1317-1327
1 reference
stated in
Europe PubMed Central
PubMed ID
16083542
retrieved
3 August 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q34559914&oldid=1754482169"